Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8630068 | Diabetes Research and Clinical Practice | 2018 | 24 Pages |
Abstract
The vast majority of patients with type 2 diabetes continue metformin after insulin initiation, consistent with guidelines. Other antihyperglycemics are frequently continued along with insulin, and further research is needed to determine which, if any, patients may benefit from this.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Scott J. Pilla, James R. Dotimas, Nisa M. Maruthur, Jeanne M. Clark, Hsin-Chieh Yeh,